Cardiovascular & hematological agents in medicinal chemistry
about
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapyCOX-inhibiting nitric oxide donors (CINODs): potential benefits on cardiovascular and renal functionAdvances in antithrombotic agentsInsights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targetsDrug-drug interactions associated with antiplatelet therapy.Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Acute coronary syndromes in patients with atrial fibrillation and heart failure. Could novel oral anticoagulants be the solution of the optimal antithrombotic therapy puzzle?Evaluation of a standardized protocol using lepirudin or argatroban for heparin-induced thrombocytopenia.Pharmacological adjuvant therapies in primary coronary interventions: bivalirudin.Emerging therapy options in heparin-induced thrombocytopenia.Fondaparinux for Management of Heparin-induced Thrombocytopenia after Cardiovascular Intervention: A Systematic Review.New Oral Anticoagulants for the Management of Heparin Induced Thrombocytopenia: A Focused Literature Review.Management and Outcome of Heparin-Induced Thrombocytopenia in Pregnancy: A Systematic Review.The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease.Ibrutinib: a new frontier in the treatment of chronic lymphocytic leukemia by Bruton's tyrosine kinase inhibitionOxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus.Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature.An evidence-based systematic review of stevia by the Natural Standard Research Collaboration.12-lipoxygenase: a potential target for novel anti-platelet therapeutics.Community expansion and gene geography of sickle cell trait and G6PD deficiency, and natural selection against malaria: experience from tribal land of India.Female sexual dysfunction: therapeutic options and experimental challenges.Imidazoline receptors, novel agents and therapeutic potential.Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises.Novel oral anticoagulants in non-valvular atrial fibrillation.The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.Proprotein convertase subtilisin/kexin type 9 (PCSK9) and LDL lowering in the contemporary management of dyslipidemia.On the role of endothelial TRPC3 channels in endothelial dysfunction and cardiovascular disease.Cardiotoxicity of 5-fluorouracil.Pharmacogenomics of essential hypertension: are we going the right way?Treatment of acute leukaemias with monoclonal antibodies: current status and future prospects.Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension.A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin.Angiotensin receptor blockers in hypertension and cardiovascular diseases.Mineralocorticoid receptor blockade in the protection of target organ damage.Platelet signaling induced by lipoproteins.Aldosterone receptor antagonists and cardiovascular disease: do we need a change of the guard?Inflammation in cardiovascular disease and regulation of the actin cytoskeleton in inflammatory cells: the actin cytoskeleton as a target.The role of thrombomodulin in atherosclerosis: from bench to bedside.Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha).
P1433
Q28196495-BAB29F3A-D728-472C-B825-460E290D9D99Q28196497-7F3B3743-D933-4153-962D-AD7A96FACAADQ28218422-AC9C9772-CAD4-4270-AA13-B51956201000Q28306940-2D722482-780B-46DB-8E8E-715298890AE3Q30454545-74ECA0E2-97FE-4076-8A53-1A099767ABA0Q33349894-F000F667-32CD-4B70-AE53-BA10132DD110Q33359271-BA19C0D7-759A-4C9A-ABF3-FE0EF0495D61Q33397089-6026E18A-0EC5-4ECB-BF85-010A37D18323Q33403211-2FA8955B-2670-47DB-904C-E49683CDDD0EQ33418568-AB09F21B-888A-49B7-9B36-3656DB61E419Q33425779-EA055CA2-8148-4DE1-AAE4-949FEB4E279CQ33428615-73CF4045-4DCB-49B7-8BE0-133B28890E0AQ33428618-A2CE6625-AA0A-42AE-9BE6-D7E0412E7657Q33538286-45F7DBA9-279A-4899-9560-6F8BEA577D00Q33566063-92DA40D5-CCCD-49BA-9928-68A4110CE818Q33659216-09214C69-C54E-421A-84CD-0F6F3B1DD5E3Q33786755-C3A8B51F-1947-472E-B538-378CCB332A88Q34000557-585064F9-873F-427C-82B3-3CD4071F88FAQ34108611-6B5ED2BF-EA61-470C-9E43-8D8921E8D16DQ34207687-4D31C383-CF8D-4213-8564-FD585E6CA474Q34248570-0F21A410-7BF7-4467-9A0E-A4A1540B5C43Q34433634-9FF918A7-61F2-4E53-B4CE-4BDAEF554A5BQ34501180-DF529518-4DE4-49CC-9BFE-EE27DF2D4515Q34578615-A53064A1-287F-4654-8FC0-87718DAFB81BQ34666804-EC16B525-A440-493F-A2F9-413757795C9BQ34803276-BFF27B3B-C39C-42C7-BFEF-59284D038FC9Q35027122-D5BD5754-0E7B-4703-815F-C4CC128C9612Q36302076-C504A24B-8A4A-4DD1-B9B5-4A9DB18399C8Q36418059-3241FED6-A431-452C-BEE6-49D4EEB70FE8Q36418063-F3DC54FB-7EDF-4CB9-99E7-829AC8245056Q36418067-03340DFB-24D8-4C1E-98BA-DEBE886A1296Q36418069-4600343F-0FE1-420D-B958-F3A053EBE8BEQ36418073-EB10BA0B-2A68-4ED8-A741-174A1A3F2DDFQ36418076-60A8E9FD-41C7-4916-B8F5-C4D37C5D59EAQ36418080-9EF899A7-0902-437D-8EF5-E91500DC6EEAQ36447102-C8B9A919-DF98-4D39-923B-5E1BE707663CQ36447106-572F6F39-59F4-4A8E-B0CF-EBE98F3583C5Q36447110-6F334D4E-901C-4A85-85C0-BE8B57C07033Q36447115-1574F245-6C83-42CA-BCA7-C7FA21D2C2BAQ36536510-67B7C7BE-6B72-4B33-9060-19E2A16444C9
P1433
Cardiovascular & hematological agents in medicinal chemistry
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Bentham Science Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Cardiovascular & hematological agents in medicinal chemistry
@ast
Cardiovascular & hematological agents in medicinal chemistry
@en
Cardiovascular & hematological agents in medicinal chemistry
@es
Cardiovascular & hematological agents in medicinal chemistry
@nl
type
label
Cardiovascular & hematological agents in medicinal chemistry
@ast
Cardiovascular & hematological agents in medicinal chemistry
@en
Cardiovascular & hematological agents in medicinal chemistry
@es
Cardiovascular & hematological agents in medicinal chemistry
@nl
altLabel
Cardiovasc Hematol Agents Med Chem
@en
prefLabel
Cardiovascular & hematological agents in medicinal chemistry
@ast
Cardiovascular & hematological agents in medicinal chemistry
@en
Cardiovascular & hematological agents in medicinal chemistry
@es
Cardiovascular & hematological agents in medicinal chemistry
@nl
P3181
P1055
P1156
4400151415
P1277
P1476
Cardiovascular & hematological agents in medicinal chemistry
@en